Salve Medica Apteka Szpitalna

Lodz 91-211

1 studies enrolling now · 2 studies all time

What they study most

Colorectal Neoplasms, HER2 Positive Breast Cancer

Studies at this site

• A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer — Recruiting now
• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling